Latest News
From the Journals
Autoimmune Diseases and Perinatal Depression May Share Two-Way Link
Study found women with autoimmune disease were 30% more likely to have perinatal depression. Risk was also 30% higher for the reverse scenario.
Feature
CMS Okays Payment for Novel AI Prostate Test
The test improves risk stratification or prognostication over standard clinical and pathologic tools, says expert.
From the Journals
Testosterone Replacement Therapy and Prostate Cancer Risk
New study suggests testosterone replacement therapy does not increase prostate cancer risk in men with hypogonadism.
From the Journals
Paget Disease of the Bone Progression Halted With Genetic Screening, Targeted Treatment
A single infusion of zoledronic acid substantially reduced existing bone lesions and biochemical markers of bone turnover over 7 years.
Latest News
Why GLP-1 Drugs Stop Working, and What to Do About It
If a patient plateaus on a GLP-1 drug, it may work to add additional drugs that have different brain targets.
Latest News
Lipids and Dementia: A Complex and Evolving Story
“It depends on what lipids you’re measuring, what you’re using to measure those lipids, what age the person is, and...
Latest News
Panel Recommends Small Bump in 2025 Medicare Physician Pay
The MedPAC vote comes amid continuing uncertainty about how much the federal government will actually pay clinicians this year through the...
From the Journals
Ozempic is Appealing, but Not Cost-Effective, for Obesity Treatment
Surgical and endoscopic options to treat obesity are cost effective, but not the pharmacological intervention semaglutide.
Latest News
Strict Glycemic Control for Renal Benefit May Come With Risk
Patients with type 2 diabetes at an elevated risk for kidney failure may face the highest overall risk for death and hypoglycemic events.
Latest News
Gestational Diabetes Treatment Moves Forward With Uncertainty And Hope
Research should yield answers on individualization of treatment and the metformin-versus-insulin controversy.
Latest News
Analysis Finds Risk of Alopecia Areata After COVID-19 Infection
The cohort consisted of 259,369 patients with COVID-19 and 259,369 uninfected controls.